WASHINGTON (AFP) A pink pill marketed by German drug firm Boehringer Ingelheimas a libido-booster for women has produced inconclusive results in two clinical trials, the US Food and Drug Administration (FDA) said.Originally intended as an anti... hypoactive sexual desire
To comment or read full article login. No account? Register free.